Skip to content

Dr Joachim Feldges

Partner

Munich

Feldges Joachim
Dr Joachim Feldges

Partner

Munich

Joachim is partner in our IP litigation practice and heads our German life sciences group. He is a dedicated patent litigation partner and has practised complex patent litigation since more than 30 years with a particular focus on pharmaceuticals, biotechnology and medical devices. 

He represents clients in infringement and validity cases before all major patent courts, the Federal Supreme Court and the Federal Patent Court and he has advised clients for many years developing and implementing international patent litigation strategies in numerous European jurisdictions. In addition, Joachim regularly represents clients in opposition proceedings before the European Patent Office. He also represents clients in arbitration proceedings and acts as an arbitrator and mediator according to the WIPO rules in IP disputes. 

Noteworthy experience includes advising:

  • A pharmaceutical company concerning the infringement of an SPC by a generic product for the treatment of epilepsy.
  • Pfizer against a parallel importer to prevent parallel imports of a medicinal product from the EU accession countries during the paediatric extension of a supplementary protection certificate including proceedings in front of the CJEU.An innovative company of genetically engineered food additives on license agreements regarding the CRISPR technology.
  • A company in a patent dispute on offshore windparks in both patent infringement and nullity proceedings with regard to the German part of a European Patent.
  • A company producing industrial machines in the automotive industry in infringement and nullity proceedings concerning a German Patent.
  • A manufacturer of mounting machines for electronic components in a multinational patent dispute.
  • A global pharmaceutical company in a dispute on a license agreement on a bispecific antibody.

News & insights

Key regulatory topics

Publications: 02 JULY 2020

CMA calls for new UK regulatory regime for online platforms to address market study concerns

On 1 July the UK Competition and Markets Authority (CMA) released the final report in its year-long market study into online platforms and digital advertising, finding a number of concerns over the…

Read more

Publications: 30 JUNE 2020

Beyond Covid-19: Emerging market private equity driving growth

This timely discussion is part of a series of Allen & Overy conversations with senior industry players to explore opportunities for recovery and growth.

Read more

Publications: 26 JUNE 2020

Covid–19 coronavirus update: an overview of European Commission State aid decisions – Updated 26 June 2020

Under State aid rules, UK and EEA Member State governments may not generally provide selective assistance to businesses without prior approval from the European Commission (EC). This includes…

Read more

Publications: 29 APRIL 2019

Practical preparations for Brexit: a global perspective

Only the very brave are predicting with certainty the outcome of attempts by the UK to leave the EU.

Read more

Office

Munich

Allen & Overy LLP
Maximilianstraße 35
80539 Munich

View office →

Qualifications

Professional

Admitted as German Rechtsanwalt, 1987

Academic

Docteur en droit, University of Geneva, Switzerland, 1987
Diplôme d’Etudes Supérieures en Droit, University of Geneva, Switzerland, 1984


Pro-bono experience

  • Joachim is since 2018 a curator for Amref Health Africa Germany and acted as an ambassador in A&O’s global charity partnership with Amref in 2014-2016.

Recognition

Published work

  • Feldges J. (2017) Handbuch des Medizinprodukterechts, 2nd Edition
  • Feldges J., Kramer B. (2011) “Intellectual Property in the Life Sciences”, Germany, pp. 193 
  • Feldges J. (2011) „Anmerkung zum Urteil des EuGH vom 18.10.2011 C-34/10 – Brüstle/Greenpeace“, GRUR 2011, pp. 1045 
  • Feldges J, Kramer B. (2010) „Die Bestimmung des Schutzbereiches von ergänzenden Schutzzertifikaten für Arzneimittel“, Festschrift für Wolfgang von Meibom, pp. 57 
  • Feldges J. (2009) „Kann die Dosierung eines Medikamentes Grundlage einer patentfähigen Erfindung sein?“ Festschrift für Thomas Reimann, pp. 91 
  • Feldges J., Kramer B. (2009) “Patent Law, in Business Laws of Germany”, 2009 ed., p. 197-305. 
  • Feldges J. (2007) „Die Durchsetzung von Patenten in europäischen Streitigkeiten“, Festschrift für Tilman Schilling, pp. 111 
  • Feldges J., Kramer B. (2007) “Co-ownership of Patents under German Law, Journal of Intellectual Property Law & Practice”, pp. 742 
  • Kilger, Feldges, Jaenichen (2005) “The Erosion of Compound Protection In Germany”, Journal of the Patent and Trademark Office Society Vol. 87, pp. 569 
  • Feldges J. (2005) „Ende des absoluten Stoffschutzes? Zur Umsetzung der Biotechnologie-Richtlinie“, GRUR 2005, pp. 977 
  • Feldges J., Kanz C. (2003) in: Anhalt/Dieners, Handbuch des Medizinprodukterechts, § 25 Schutz von Medizinprodukten durch technische Schutzrechte, Munich